Pharvaris NV (PHVS)
24.31
+0.86
(+3.67%)
USD |
NASDAQ |
Apr 30, 16:00
24.43
+0.12
(+0.49%)
After-Hours: 20:00
Pharvaris Total Liabilities (Quarterly): 16.19M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.19M |
| September 30, 2023 | 17.16M |
| June 30, 2023 | 17.40M |
| March 31, 2023 | 20.34M |
| December 31, 2022 | 19.81M |
| September 30, 2022 | 17.51M |
| June 30, 2022 | 16.89M |
| March 31, 2022 | 11.43M |
| Date | Value |
|---|---|
| December 31, 2021 | 8.081M |
| September 30, 2021 | 8.890M |
| June 30, 2021 | 8.922M |
| March 31, 2021 | 9.908M |
| December 31, 2020 | 6.536M |
| September 30, 2020 | 5.124M |
| December 31, 2019 | 2.155M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.155M
Minimum
Dec 2019
20.34M
Maximum
Mar 2023
12.42M
Average
11.43M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| uniQure NV | 624.02M |
| ProQR Therapeutics NV | 106.66M |
| Merus NV | 99.15M |
| argenx SE | 444.95M |
| Pharming Group | 244.07M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 440.72M |
| Shareholders Equity (Quarterly) | 424.53M |